{"organizations": [], "uuid": "a29c78afc331309d27740d148a7937f47a740412", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-tandem-diabetes-care-sees-q4-2017/brief-tandem-diabetes-care-sees-q4-2017-gaap-sales-of-about-39-mln-to-40-mln-idUSASB0C0G7", "country": "US", "domain_rank": 408, "title": "BRIEF-Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-10T01:33:00.000+02:00", "replies_count": 0, "uuid": "a29c78afc331309d27740d148a7937f47a740412"}, "author": "", "url": "https://www.reuters.com/article/brief-tandem-diabetes-care-sees-q4-2017/brief-tandem-diabetes-care-sees-q4-2017-gaap-sales-of-about-39-mln-to-40-mln-idUSASB0C0G7", "ord_in_thread": 0, "title": "BRIEF-Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "tandem diabetes care inc", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 35 PM / in 28 minutes BRIEF-Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln Reuters Staff \nJan 9 (Reuters) - Tandem Diabetes Care Inc: \n* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE * SEES FY 2018 SALES $132 MILLION TO $140 MILLION * SEES FY 2018 SALES UP ABOUT 23 TO 32 PERCENT \n* - PRELIMINARY Q4 ‍GAAP SALES INCREASED TO APPROXIMATELY $39 MILLION TO $40 MILLION FROM $28.9 MILLION IN 2016​ \n* TANDEM DIABETES CARE - EXPECT Q4 PUMP SHIPMENTS INCREASED TO ABOUT 7,000 PUMPS \n* - 2018 GAAP SALES ARE ESTIMATED TO BE IN RANGE OF $132 MILLION TO $140 MILLION \n* FY2018 REVENUE VIEW $133.6 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-10T01:33:00.000+02:00", "crawled": "2018-01-10T01:56:28.011+02:00", "highlightTitle": ""}